Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | -3.97% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.58 | N/A | -3.97% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management acknowledged the tough market conditions but remains hopeful about future opportunities. They did not provide specific guidance for the upcoming quarters.
Management highlighted ongoing challenges in the market.
They expressed confidence in long-term growth despite current hurdles.
Itron Inc's earnings report showed a slight miss on EPS, which contributed to a small decline in stock price. The company did not provide revenue figures or future guidance, leaving investors uncertain about its short-term outlook. The stock reaction reflects cautious sentiment among investors in light of the current market challenges.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HAEMONETICS CORP MAS